Figure 2.
TFF1 expression and intensity in T47D cells treated with (), benzophenone-3 (BP-3), or propylparaben (PP) for with or without the ER antagonist fulvestrant. (A) Inhibition of TFF1 expression following treatment of , BP-3, and PP when cotreated with fulvestrant (ICI 182 780, ) compared with , BP-3, and PP treatments without fulvestrant. (B) Quantification of nuclear following cotreatment of fulvestrant () with (), BP-3 (), or PP () compared with (), BP-3 (), or PP () without fulvestrant treatment, respectively. *** compared control to xenoestrogens treatment and ### compared with negative fulvestrant and with positive fulvestrant using multiple comparison for 2-way ANOVA. biological replicates. All graphs show mean ± SEM.